Microbiological titration of antibiotics (2)

👉 The antibiotics landscape is evolving fast, driven by the growth of hospital injectables (β-lactams, glycopeptides, carbapenems) and the rise of narrow-spectrum therapies. In this context, pharma companies face increasingly demanding analytical requirements for batch release, stability, and regulatory compliance.

🔬 Unique Expertise

At CEBIPHAR, our teams support you through :

• A dual, recognized expertise : microbiology titration (potency assays, diffusion, and HPLC)

• Full proficiency in Ph. Eur. and USP methods, applied to both APIs and finished products.

• Flexible engagement models: method optimization, (re)validation & transfer, QC testing.

🔎 Discover our solution through this case study :

🤝 Ready to move your projects forward ? Let’s talk !

Our teams are available to discuss your needs, contact us !